Y
Yinzhong Shen
Publications - 13
Citations - 2181
Yinzhong Shen is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 1985 citations.
Papers
More filters
Journal ArticleDOI
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Rongbao Gao,Bin Cao,Yunwen Hu,Zijian Feng,Dayan Wang,Wanfu Hu,Jian Chen,Zhijun Jie,Haibo Qiu,Ke Xu,Xuewei Xu,Hongzhou Lu,Wenfei Zhu,Zhancheng Gao,Nijuan Xiang,Yinzhong Shen,Zebao He,Y. Gu,Zhiyong Zhang,Yi Yang,Xiang Zhao,Lei Zhou,Xiaodan Li,Shumei Zou,Ye Zhang,Xiyan Li,Lei Yang,Junfeng Guo,Jie Dong,Qun Li,Libo Dong,Yun Zhu,Tian Bai,Shiwen Wang,Pei Hao,Weizhong Yang,Yanping Zhang,Jun Han,Hongjie Yu,Dexin Li,George F. Gao,Guizhen Wu,Yu Wang,Zhenghong Yuan,Yuelong Shu +44 more
TL;DR: Novel reassortant H7N9 viruses were associated with severe and fatal respiratory disease in three patients, and all three patients died.
Journal ArticleDOI
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
Yinzhong Shen,Jing-Wen Ai,Na Lin,Haocheng Zhang,Yang Li,Hongyu Wang,Sen Wang,Zhen Ping Wang,Tao Li,Feng Sun,Zhenyu Fan,Liqun Li,Yunfei Lu,Xianmin Meng,Hong Xiao,Hu Hu,Yun Ling,Feng Li,Hongdi Li,Chunmei Xi,Liping Gu,Wen Zhang,Xiao-Bo Fan +22 more
TL;DR: V116 is a safe, effective oral antiviral drug, which shows a better performance within the early onset of omicron infection, and is evaluated in Chinese participants infected with SARS-CoV-2 from March 8th, 2022 to March 24th of 2022.
Journal ArticleDOI
An early warning system for emerging SARS-CoV-2 variants
Lorenzo Subissi,Anne von Gottberg,Lipi Thukral,Nathalie Worp,Bas B. Oude Munnink,Surabhi Rathore,Laith J. Abu-Raddad,Ximena Aguilera,E. A. Alm,Brett N. Archer,Homa Attar Cohen,Amal Barakat,Wendy S. Barclay,Jinal N. Bhiman,Leon Caly,Meera Chand,Mark Chen,Ann Cullinane,Tulio de Oliveira,Christian Drosten,Julian Druce,P Effler,Ihab El Masry,Adama Faye,Simani Gaseitsiwe,Elodie Ghedin,Rebecca L. Grant,Bart L. Haagmans,Belinda L. Herring,Shilpa S Iyer,Zyleen Kassamali,Manish Kakkar,Rebecca Kondor,Juliana Alves Leite,Yee Sin Leo,Gabriel M. Leung,Marco Marklewitz,Sikhulile Moyo,Jairo Mendez-Rico,Nada M. Melhem,Vincent J. Munster,Karen Martun Nahapetyan,Djin-Ye Oh,Boris I. Pavlin,Thomas P. Peacock,Malik Peiris,Zhibin Peng,Leo L. M. Poon,Andrew Rambaut,Jilian A. Sacks,Yinzhong Shen,Marilda M. Siqueira,Sofonias K. Tessema,Erik M. Volz,Volker Thiel,S. Van Der Werf,Sylvie Briand,Mark D. Perkins,Maria D. Van Kerkhove,Marion Koopmans,Anurag Agrawal +60 more
TL;DR: In this paper , global sequencing and surveillance capacity for SARS-CoV-2 must be strengthened and combined with multidisciplinary studies of infectivity, virulence and immune escape, in order to track the unpredictable evolution of the ongoing COVID-19 pandemic.
Journal ArticleDOI
Multi-dimensional mismatch and barriers for promoting PrEP among men who have sex with men in China: a cross sectional survey from the Demand-side
Yuan-Yuan Guan,Tangkai Qi,Qibin Liao,Renfang Zhang,Jun Chen,Lei Liu,Yinzhong Shen,Han Zhu,Liang Tang,Hongzhou Lu +9 more
TL;DR: Wang et al. as discussed by the authors assessed the barriers in the acknowledgement and uptake of pre-exposure prophylaxis (PrEP) focusing on demand side and found that a wide disconnect exists among the objective need, willingness, affordability and uptake.
Journal ArticleDOI
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
Yuqi Zhu,Xinyi Yang,Jingna Xun,Jun Lu,Qing Wen,Yixiao Lin,Xiaoting Shen,Jun Chen,Songhua Yuan,Xiaying Zhao,Jing Wang,Hanyu Pan,Jinlong Yang,Zhiming Liang,Yue Liang,Q. Lin,Huitong Liang,Min Lin,Jianping Liu,Yinzhong Shen,Xiaogang Zhang,Pengfei Wang,Daru Lu,Chunhua Yin,Jianming Xu,Shibo Jiang,Hongzhou Lu,Huanzhang Zhu +27 more
TL;DR: In this paper , the authors constructed pseudoviruses of five VOCs using a lentiviral-based system and analyzed their viral infectivity and neutralization resistance to convalescent and BBIBP-CorV vaccinee serum at different times.